Low-dose Hormone Therapy in Postmenopausal Women.
- Author:
So Ra KIM
1
;
Hee Dong CHAE
Author Information
1. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. hdchae@amc.seoul.kr
- Publication Type:Review
- Keywords:
Low-dose hormone therapy;
Menopause;
Risk;
Benefit
- MeSH:
Atrophy;
Breast Diseases;
Female;
Humans;
Menopause
- From:The Journal of Korean Society of Menopause
2010;16(2):65-70
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The importance of the results of some large, randomized controlled trials on hormone therapy (HT) has changed the perceived risk or benefit of HT. It is now recommended that the dose and regimen of HT should be individualized based on the principle of choosing the lowest appropriate dose in relation to the severity of symptoms and age of menopause. The effectiveness of low and ultra-low dose HT has been demonstrated for the treatment of vasomotor symptoms, genital atrophy and the prevention of bone loss with fewer side-effects than the standard dose HT. Although accumulating evidence demonstrates the efficacy and tolerability of low-dose HT, data about the use are limited by a lack of long-term, randomized studies. Further research is needed to determine the effect on fractures, as well as cardiovascular and breast disease.
